Compare Dover Corp (DOV) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dover Corp vs Oscar Health Inc — how do they compare? Dover Corp trades at $188.83 (market cap $25.45B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Dover Corp is far larger — about 2.5× Oscar Health Inc's market cap, and Dover Corp pays a 1.11% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dover Corp for 73 Days and Oscar Health Inc for 15 Days on average.
| DOV | OSCR | |
|---|---|---|
Market Cap | $25.45B | $10.22B |
Volume | 661,758 | 4,123,394 |
Sector | Industrials | Health |
52-Week High | $233.31 | $33.81 |
52-Week Low | $161.16 | $10.85 |
Typical Hold Time | 73 Days | 15 Days |
Enterprise Value | $26.95B | $6.57B |
Dividend Yield | 1.11% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dover Corporation (DOV) trades at $188.96, up 0.36% today, with a bearish technical signal from moving averages but neutral oscillators. The company maintains solid fundamentals, with a P/E of 22.85 and net income margin of 13.48%, while consistently beating EPS estimates in recent quarters. Recent news highlights product launches and strategic acquisitions, such as the completion of Cloeren's purchase, reinforcing growth initiatives.
The outlook is positive, supported by a strong analyst consensus with a $243.20 price target and no sell ratings. Risks include market volatility and execution of acquisition integration, but robust cash flow and dividend history provide stability. Upside potential hinges on continued earnings outperformance and sector tailwinds.
OSCR trades at $33.10, up 0.58% with a bullish technical signal and strong institutional support. Recent earnings show volatility with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Analyst consensus is mixed with 30.77% buy ratings and a $34.00 price target, slightly above current levels.
The outlook is cautiously optimistic with strong revenue growth and profitability improvements, though risks include medical cost pressures and competitive ACA market dynamics. Upside potential exists if margin expansion continues, but investors should monitor execution against guidance and healthcare sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
